Table 3.
CD3 T-cell infiltration and DGMate score in primary tumor and brain metastases according to BM site and BM numbers.
| Primary Tumor | Brain Metastases | |||||
|---|---|---|---|---|---|---|
| n | CD3 area* | DGMate | n | CD3 area* | DGMate | |
| Site of primary tumor | ||||||
| Colon | 42 | 54.9 ± 15.9 | 1.9 ± 0.1 | 24 | 16.0 ± 17.5 | 2.0 ± 0.1 |
| Rectum | 34 | 108.7 ± 30.4 | 2.1 ± 0.1 | 12 | 28.2 ± 12.5 | 2.0 ± 0.1 |
| Site of BM | ||||||
| Supratentorial only | 46 | 53.9 ± 17.5 | 2.0 ± 0.1 | 23 | 15.3 ± 5.5 | 1.9 ± 0.1 |
| Subtentorial only | 16 | 85.7 ± 31.2 | 2.0 ± 0.1 | 13 | 17.4 ± 5.1 | 2.0 ± 0.1 |
| Supra and subtentorial | 18 | 137.1 ± 42.8 | 2.0 ± 0.1 | 1 | 113.2 | 2.2 |
| Number of BM | ||||||
| Unique BM | 39 | 64.6 ± 21.3 | 2.0 ± 0.1 | 30 | 15.8 ± 4.7 | 1.9 ± 0.1 |
| Multiple BM | 41 | 92.1 ± 22.6 | 2.0 ± 0.1 | 7 | 32.9 ± 16.6 | 2.2 ± 0.1 |
* Mean CD3 infiltration was expressed by mm3.